These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 34624627)
1. Oxidative metabolism and pharmacokinetics of the EGFR inhibitor BIBX1382 in chimeric NOG-TKm30 mice transplanted with human hepatocytes. Uehara S; Yoneda N; Higuchi Y; Yamazaki H; Suemizu H Drug Metab Pharmacokinet; 2021 Dec; 41():100419. PubMed ID: 34624627 [TBL] [Abstract][Full Text] [Related]
2. Cynomolgus monkey as a surrogate for human aldehyde oxidase metabolism of the EGFR inhibitor BIBX1382. Hutzler JM; Cerny MA; Yang YS; Asher C; Wong D; Frederick K; Gilpin K Drug Metab Dispos; 2014 Oct; 42(10):1751-60. PubMed ID: 25035284 [TBL] [Abstract][Full Text] [Related]
3. Human Aldehyde Oxidase 1-Mediated Carbazeran Oxidation in Chimeric TK-NOG Mice Transplanted with Human Hepatocytes. Uehara S; Yoneda N; Higuchi Y; Yamazaki H; Suemizu H Drug Metab Dispos; 2020 Jul; 48(7):580-586. PubMed ID: 32357972 [TBL] [Abstract][Full Text] [Related]
4. The Unique Human N10-Glucuronidated Metabolite Formation from Olanzapine in Chimeric NOG-TKm30 Mice with Humanized Livers. Uehara S; Higuchi Y; Yoneda N; Kato H; Yamazaki H; Suemizu H Drug Metab Dispos; 2023 Apr; 51(4):480-491. PubMed ID: 36623885 [TBL] [Abstract][Full Text] [Related]
5. UDP-glucuronosyltransferase 1A4-mediated N2-glucuronidation is the major metabolic pathway of lamotrigine in chimeric NOG-TKm30 mice with humanised-livers. Uehara S; Higuchi Y; Yoneda N; Yamazaki H; Suemizu H Xenobiotica; 2021 Oct; 51(10):1146-1154. PubMed ID: 34423713 [TBL] [Abstract][Full Text] [Related]
6. Species-Specific Involvement of Aldehyde Oxidase and Xanthine Oxidase in the Metabolism of the Pyrimidine-Containing mGlu Crouch RD; Blobaum AL; Felts AS; Conn PJ; Lindsley CW Drug Metab Dispos; 2017 Dec; 45(12):1245-1259. PubMed ID: 28939686 [TBL] [Abstract][Full Text] [Related]
7. SGX523 causes renal toxicity through aldehyde oxidase-mediated less-soluble metabolite formation in chimeric mice with humanized livers. Uehara S; Yasuda M; Higuchi Y; Yoneda N; Kawai K; Suzuki M; Yamazaki H; Suemizu H Toxicol Lett; 2023 Oct; 388():48-55. PubMed ID: 37806366 [TBL] [Abstract][Full Text] [Related]
8. Characterization of aldehyde oxidase enzyme activity in cryopreserved human hepatocytes. Hutzler JM; Yang YS; Albaugh D; Fullenwider CL; Schmenk J; Fisher MB Drug Metab Dispos; 2012 Feb; 40(2):267-75. PubMed ID: 22031625 [TBL] [Abstract][Full Text] [Related]
9. Molecular Cloning and Characterization of Marmoset Aldehyde Oxidase. Uehara S; Uno Y; Okamoto E; Inoue T; Sasaki E; Yamazaki H Drug Metab Dispos; 2017 Aug; 45(8):883-886. PubMed ID: 28487309 [TBL] [Abstract][Full Text] [Related]
10. A novel in vitro allometric scaling methodology for aldehyde oxidase substrates to enable selection of appropriate species for traditional allometry. Crouch RD; Hutzler JM; Daniels JS Xenobiotica; 2018 Mar; 48(3):219-231. PubMed ID: 28281401 [TBL] [Abstract][Full Text] [Related]
11. Prediction of human metabolism of FK3453 by aldehyde oxidase using chimeric mice transplanted with human or rat hepatocytes. Sanoh S; Nozaki K; Murai H; Terashita S; Teramura T; Ohta S Drug Metab Dispos; 2012 Jan; 40(1):76-82. PubMed ID: 21984595 [TBL] [Abstract][Full Text] [Related]
12. Expression and functional activity of cytochrome P450 enzymes in human hepatocytes with sustainable reproducibility for in vitro phenotyping studies. Bachour-El Azzi P; Chesné C; Uehara S Adv Pharmacol; 2022; 95():285-305. PubMed ID: 35953158 [TBL] [Abstract][Full Text] [Related]
13. An improved TK-NOG mouse as a novel platform for humanized liver that overcomes limitations in both male and female animals. Uehara S; Higuchi Y; Yoneda N; Kawai K; Yamamoto M; Kamimura H; Iida Y; Oshimura M; Kazuki Y; Yamazaki H; Hikita H; Takehara T; Suemizu H Drug Metab Pharmacokinet; 2022 Feb; 42():100410. PubMed ID: 34839181 [TBL] [Abstract][Full Text] [Related]
14. In Vitro Metabolism by Aldehyde Oxidase Leads to Poor Pharmacokinetic Profile in Rats for c-Met Inhibitor MET401. Zhang JW; Deng HB; Zhang CY; Dai JQ; Li Q; Zheng QG; Wan HX; Yu HP; He F; Xu YC; Zhao S; Zhang JYJ Eur J Drug Metab Pharmacokinet; 2019 Oct; 44(5):669-680. PubMed ID: 31030415 [TBL] [Abstract][Full Text] [Related]
15. Species differences in enantioselective 2-oxidations of RS-8359, a selective and reversible MAO-A inhibitor, and cinchona alkaloids by aldehyde oxidase. Itoh K; Yamamura M; Takasaki W; Sasaki T; Masubuchi A; Tanaka Y Biopharm Drug Dispos; 2006 Apr; 27(3):133-9. PubMed ID: 16400710 [TBL] [Abstract][Full Text] [Related]
16. Methyl-hydroxylation and subsequent oxidation to produce carboxylic acid is the major metabolic pathway of tolbutamide in chimeric TK-NOG mice transplanted with human hepatocytes. Uehara S; Yoneda N; Higuchi Y; Yamazaki H; Suemizu H Xenobiotica; 2021 May; 51(5):582-589. PubMed ID: 33455497 [TBL] [Abstract][Full Text] [Related]
17. Lack of Exposure in a First-in-Man Study Due to Aldehyde Oxidase Metabolism: Investigated by Use of 14C-microdose, Humanized Mice, Monkey Pharmacokinetics, and In Vitro Methods. Jensen KG; Jacobsen AM; Bundgaard C; Nilausen DØ; Thale Z; Chandrasena G; Jørgensen M Drug Metab Dispos; 2017 Jan; 45(1):68-75. PubMed ID: 27737930 [TBL] [Abstract][Full Text] [Related]
18. Inhibitory effects of drugs on the metabolic activity of mouse and human aldehyde oxidases and influence on drug-drug interactions. Takaoka N; Sanoh S; Okuda K; Kotake Y; Sugahara G; Yanagi A; Ishida Y; Tateno C; Tayama Y; Sugihara K; Kitamura S; Kurosaki M; Terao M; Garattini E; Ohta S Biochem Pharmacol; 2018 Aug; 154():28-38. PubMed ID: 29678521 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of rhesus monkey and guinea pig hepatic cytosol fractions as models for human aldehyde oxidase. Choughule KV; Barr JT; Jones JP Drug Metab Dispos; 2013 Oct; 41(10):1852-8. PubMed ID: 23918666 [TBL] [Abstract][Full Text] [Related]
20. Human plasma concentrations of cytochrome P450 probe cocktails extrapolated from pharmacokinetics in mice transplanted with human hepatocytes and from pharmacokinetics in common marmosets using physiologically based pharmacokinetic modeling. Utoh M; Suemizu H; Mitsui M; Kawano M; Toda A; Uehara S; Uno Y; Shimizu M; Sasaki E; Yamazaki H Xenobiotica; 2016 Dec; 46(12):1049-1055. PubMed ID: 26916082 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]